Role of Sodium-Glucose Transport Protein-2 Inhibitors in Renal Protection: A Narrative Review from the Cardiovascular-Kidney-Metabolic Interconnection
Drug Design, Development and Therapy · 2026
DOI: 10.2147/dddt.s540082 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Nan Ye und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.
ORCID-Profile: Nan Ye, Hong Cheng
Zitieren
APA
Ye, N., & Cheng, H. (2026). Role of Sodium-Glucose Transport Protein-2 Inhibitors in Renal Protection: A Narrative Review from the Cardiovascular-Kidney-Metabolic Interconnection. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s540082
Vancouver
Ye N, Cheng H. Role of Sodium-Glucose Transport Protein-2 Inhibitors in Renal Protection: A Narrative Review from the Cardiovascular-Kidney-Metabolic Interconnection. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s540082
BibTeX
@article{Ye2026,
author = {Ye, Nan and Cheng, Hong},
title = {Role of Sodium-Glucose Transport Protein-2 Inhibitors in Renal Protection: A Narrative Review from the Cardiovascular-Kidney-Metabolic Interconnection},
journal = {Drug Design, Development and Therapy},
year = {2026},
doi = {10.2147/dddt.s540082}
}
EUVIMED